[EN] REVERSIBLE LYSINE COVALENT MODIFIERS OF EGFR AND USES THEREOF [FR] MODIFICATEURS COVALENTS DE LYSINE RÉVERSIBLES DE L'EGFR ET LEURS UTILISATIONS
摘要:
EGFR is a frequently overexpressed protein in certain human cancers. Disclosed herein are compositions and methods for the modulation EGFR proteins, specifically EGFR mutants comprising single, double, or triple mutations.
Organocatalytic Route to Dihydrocoumarins and Dihydroquinolinones in All Stereochemical Configurations
摘要:
A straightforward stereodivergent route to dihydrocoumarins and dihydroquinolinones based on cinchona alkaloid catalyzed addition reactions of monothiomalonates (MTMs) to functionalized nitroolefins followed by deprotection and chemoselective cyclization has been developed. The synthesis proceeds under mild conditions and yields heterocycles with adjacent quaternary and tertiary stereogenic centers in very high yields and stereoselectivities. Moreover, full control over the relative and absolute configuration is achieved by the use of (pseudo)enantiomeric catalysts and the difference in reactivity of thioester versus oxoester moieties.
Organocatalytic Route to Dihydrocoumarins and Dihydroquinolinones in All Stereochemical Configurations
作者:Oliver D. Engl、Sven P. Fritz、Alexander Käslin、Helma Wennemers
DOI:10.1021/ol502697s
日期:2014.10.17
A straightforward stereodivergent route to dihydrocoumarins and dihydroquinolinones based on cinchona alkaloid catalyzed addition reactions of monothiomalonates (MTMs) to functionalized nitroolefins followed by deprotection and chemoselective cyclization has been developed. The synthesis proceeds under mild conditions and yields heterocycles with adjacent quaternary and tertiary stereogenic centers in very high yields and stereoselectivities. Moreover, full control over the relative and absolute configuration is achieved by the use of (pseudo)enantiomeric catalysts and the difference in reactivity of thioester versus oxoester moieties.
[EN] REVERSIBLE LYSINE COVALENT MODIFIERS OF EGFR AND USES THEREOF<br/>[FR] MODIFICATEURS COVALENTS DE LYSINE RÉVERSIBLES DE L'EGFR ET LEURS UTILISATIONS
申请人:[en]TERREMOTO BIOSCIENCES, INC.
公开号:WO2023070114A2
公开(公告)日:2023-04-27
EGFR is a frequently overexpressed protein in certain human cancers. Disclosed herein are compositions and methods for the modulation EGFR proteins, specifically EGFR mutants comprising single, double, or triple mutations.